5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.59▼ | 1.59▼ | 1.60▼ | 1.62▼ | 1.58▼ |
MA10 | 1.60▼ | 1.62▼ | 1.62▼ | 1.68▼ | 1.52▲ |
MA20 | 1.63▼ | 1.63▼ | 1.62▼ | 1.61▼ | 1.62▼ |
MA50 | 1.64▼ | 1.68▼ | 1.69▼ | 1.51▲ | 1.80▼ |
MA100 | 1.69▼ | 1.67▼ | 1.61▼ | 1.63▼ | 1.48▲ |
MA200 | 1.69▼ | 1.54▲ | 1.52▲ | 1.66▼ | 1.31▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.005▼ | -0.004▼ | -0.012▼ | 0.015▲ |
RSI | 31.932▼ | 35.282▼ | 35.381▼ | 49.201▼ | 49.039▼ |
STOCH | 13.333▼ | 8.004▼ | 7.835▼ | 20.924 | 43.615 |
WILL %R | -86.364▼ | -90.323▼ | -90.323▼ | -88.889▼ | -61.527 |
CCI | -118.644▼ | -102.566▼ | -107.113▼ | -94.754 | 33.800 |
RSI | $PFIE RSI(14) Crossed Below 50 | Set Alert |
Friday, July 26, 2024 12:55 PM
Argus raised the price target for the Pfizer Inc. (NYSE:PFE) stock from “a Buy” to “a Hold”. The rating was released on March 22, 2024, according to finviz. The research report from TD Cowen has ...
|
Friday, July 26, 2024 06:59 AM
The company is likely to see higher sales, led by an uptick in Eliquis and Prevnar sales. However, we think that the top-line may fall short of analyst expectations..
|
Friday, July 26, 2024 05:37 AM
Merck's (MRK) blockbuster product, Keytruda, is endorsed in the EU in combination with Pfizer’s (PFE) Padcev for a type of bladder cancer. Read more here.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/07/24 | 1.64 | 1.6425 | 1.56 | 1.58 | 78,633 |
25/07/24 | 1.615 | 1.715 | 1.59 | 1.61 | 91,399 |
24/07/24 | 1.60 | 1.62 | 1.599 | 1.61 | 88,934 |
23/07/24 | 1.66 | 1.70 | 1.60 | 1.60 | 118,181 |
22/07/24 | 1.68 | 1.6975 | 1.66 | 1.68 | 48,917 |
19/07/24 | 1.64 | 1.70 | 1.62 | 1.66 | 61,257 |
18/07/24 | 1.695 | 1.695 | 1.65 | 1.655 | 80,294 |
17/07/24 | 1.78 | 1.80 | 1.70 | 1.74 | 122,812 |
16/07/24 | 1.84 | 1.85 | 1.70 | 1.78 | 259,359 |
15/07/24 | 1.72 | 1.86 | 1.68 | 1.845 | 568,325 |
|
|
||||
|
|
||||
|
|